Karyopharm Therapeutics | KPTI - سرمایه عادی

قیمت سهام
7.63
تغییر روزانه
-0.10 -1.29%
ماهیانه
-23.93%
سالیانه
18.85%
Q1 پیش بینی
7.40




سرمایه عادی تغییر دادن تاریخ
AbbVie USD 1.77B 1.75B 2025-06
Abbott USD 1.74B 23.39B 2025-09
Amgen USD 539M 1000K 2025-12
AstraZeneca USD 1.55B 206K 2025-12
BioCryst Pharmaceuticals USD 213.06M 2.54M 2025-12
Bristol-Myers Squibb USD 2.04B 1.74B 2025-09
Eli Lilly USD 946.83M 354.23M 2025-06
Enanta Pharmaceuticals USD 212K 1000 2023-12
GlaxoSmithKline GBP 4.08B 49.43M 2025-12
Incyte USD 198.46M 2.33M 2025-12
J&J USD 2.41B 584K 2025-09
Karyopharm Therapeutics USD 13K 0 2024-09
MacroGenics USD 63.32M 60K 2025-12
Merck USD 2.49B 15.79M 2025-09
Nektar Therapeutics USD 19K 0 2024-09
Novartis USD 1.91B 10.64M 2025-12
Novartis USD 1.91B 10.64M 2025-12
Pfizer USD 5.69B 1000K 2025-09
Regeneron Pharmaceuticals USD 105.3M 1.1M 2025-09
Roche Holding CHF 795.62M 699.54K 2025-12
Takeda JPY 1.58B 2K 2025-12
Tectonic Therapeutic USD 18.74M 25.03K 2025-12
TG Therapeutics USD 155.21M 2.81M 2025-09
Ultragenyx Pharmaceutical USD 96.44M 88K 2025-09
Xencor USD 71.87M 529K 2025-12